Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
4 Bank of America Strong Buy Growth 10 Stocks That All Pay Dividends
07:17am, Wednesday, 08'th Oct 2025
BofA Securities is the investment banking and capital markets division of Bank of America, one of the largest financial institutions in the United States.
Gilead Resolves Patent Litigations for HIV Treatment Biktarvy
10:42am, Tuesday, 07'th Oct 2025
Gilead's settlement on Biktarvy patents delays generic entry until 2036, boosting investor confidence.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
2 Surefire Dividend Stocks to Buy for the Long Haul
09:37am, Saturday, 04'th Oct 2025
Equity markets experienced significant volatility this year. Many investors feared that President Donald Trump's aggressive trade policies would plunge the economy into a recession and lead to a full-
Gilead Sciences (GILD) Laps the Stock Market: Here's Why
07:00pm, Friday, 03'rd Oct 2025
Gilead Sciences (GILD) reached $112.69 at the closing of the latest trading day, reflecting a +1.93% change compared to its last close.
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Thursday, 02'nd Oct 2025
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Dividend Shields: Top 5 Income Stocks
12:55pm, Tuesday, 30'th Sep 2025
Market optimism has waned as investors weighed mixed data, Fed guidance, and sector-specific risks after the S&P 500 hit eight record highs in September. Strong GDP and jobs data have tempered rate cu
Hanmi's Oral Delivery Platform Compound Licensed to Gilead
05:45am, Monday, 29'th Sep 2025
Hanmi and HHP will grant Gilead an exclusive license to Encequidar and provide access to drug supply. SEOUL, South Korea , Sept.
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors
07:01pm, Thursday, 25'th Sep 2025
Gilead Sciences (GILD) concluded the recent trading session at $110.99, signifying a -2.36% move from its prior day's close.
Gilead Foundation Grants $6.5 Million in Commitment to STEM Education
08:00am, Thursday, 25'th Sep 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has committed more than $6.5 million in grant funding toward strengthening science, technology, engin
Gilead Sciences Surges 26.5% YTD: Buy, Sell or Hold the Stock?
11:20am, Wednesday, 24'th Sep 2025
Gilead surges 26.5% YTD in 2025 as HIV franchise gains momentum with Yeztugo approval, offsetting cell therapy pressures.
Gilead Sciences: Yeztugo And Trodelvy Make This A Buy Once More
06:45pm, Tuesday, 23'rd Sep 2025
Gilead Sciences is upgraded to 'Buy' as YEZTUGO's FDA approval strengthens its dominant HIV franchise and long-term outlook. GILD's valuation remains attractive, with a P/E of 14.74 and significant up
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
10:01am, Thursday, 18'th Sep 2025
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Fangzhou Wins Gilead ‘Award of Excellence' for AI-Driven Chronic Disease Management
09:16pm, Wednesday, 17'th Sep 2025
SHANGHAI, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, received the “Excellence Award” at Gilead
Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note
07:01pm, Wednesday, 17'th Sep 2025
Gilead Sciences (GILD) reached $112.26 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.
